Theragnostic

In this topical collection (10 articles)

1. Original Article

   Intraindividual comparison of [¹⁷⁷Lu]Lu-DOTA-EB-TATE and [¹⁷⁷Lu]Lu-DOTA-TOC

   Heribert Hänscheid, Philipp E. Hartrampf… Pages 1-7

   Download PDF (674KB) View Article

2. Original Article

   Equivalent tumor detection for early and late FAPI-46 PET acquisition

   J. Ferdinandus, L. Kessler, N. Hirmas… Pages 1-7

   Download PDF (1745KB) View Article

3. 

   Original Article

   Therapy-related myeloid neoplasm after peptide receptor radionuclide therapy (PRRT) in 1631 patients from our 20 years of experiences: prognostic parameters and overall survival

   M. Chantadisai, H. R. Kulkarni, R. P. Baum Pages 1-9

4. 

   Original Article

   Long-term outcome of “Sandwich” chemo-PRRT: a novel treatment strategy for metastatic neuroendocrine tumors with both FDG- and SSTR-avid aggressive disease

   Rahul V. Parghane, Vikas Ostwal… Pages 1-11

5. Review Article

   HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging

   Betül Altunay, Agnieszka Morgenroth… Pages 1-19

   Download PDF (1758KB) View Article

6. 

   Original Article

   Response and outcome of liver metastases in patients with metastatic castration-resistant prostate cancer (mCRPC) undergoing ¹⁷⁷Lu-PSMA-617 radioligand therapy

   Fadi Khreish, Niklas Kochems, Florian Rosar… Pages 103-112

7. 

   Short Communication

   New insights in the paradigm of upregulation of tumoral PSMA expression by androgen receptor blockade: Enzalutamide induces PSMA upregulation in castration-resistant prostate cancer even in patients having previously progressed on enzalutamide

   Florian Rosar, Sebastian Dewes, Martin Ries… Pages 687-694

8. Original Article

   The ⁶⁸Ga/¹⁷⁷Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up

   Johanna Maffey-Steffan, Lorenza Scarpa… Pages 695-712

   Download PDF (828KB) View Article

9. 

   Original Article

   ²²⁵Ac-PSMA-617/¹⁷⁷Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience

   Fadi Khreish, Niklas Ebert, Martin Ries… Pages 721-728

10. 

    Interview

    Pathologist at the doorstep of cancer “I know your weaknesses and strength”: an interview with Jean Claude Reubi

    Vikas Prasad Pages 741-743